Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

A Phase I Study to Evaluate the Safety of the the Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects
Condition:   Gastroenteritis Interventions:   Biological: Recombinant Norovirus Hexavalent Vaccine;   Other: Matching Placebo Sponsors:   Syneos Health;   Chengdu Kanghua Biological products Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2023 Category: Research Source Type: clinical trials